Cyclin-dependent kinase inhibitor 3 (CDKN3) novel cell cycle computational network between human non-malignancy associated hepatitis/cirrhosis and hepatocellular carcinoma (HCC) transformation

Cell Proliferation

Volumn 44, Issue 3, 2011, Pages 291-299

  Wang, L ^a   Sun, L ^a   Huang, J ^a   Jiang, M ^b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 3;

ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE PARAMETERS; CELL DIVISION; CONTROLLED STUDY; CYCLIN DEPENDENT KINASE INHIBITOR 3 GENE; CYTOKINESIS; DISEASE ASSOCIATION; DNA REPLICATION; GENE; GENE REGULATORY NETWORK; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRANSFORMATION; HEPATITIS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PROTEIN DEGRADATION;

ALGORITHMS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; COMPUTATIONAL BIOLOGY; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; DUAL-SPECIFICITY PHOSPHATASES; FIBROSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HEPATITIS; HUMANS; LIVER NEOPLASMS; MODELS, BIOLOGICAL; NEURAL NETWORKS (COMPUTER); OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 79955448835     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00752.x     Document Type: Article

References (46)

1. Dai Y, Grant S (2006) CDK inhibitor targets: a hit or miss proposition?: cyclin-dependent kinase inhibitors kill tumor cells by downregulation of anti-apoptotic proteins. Cancer Biol. Ther. 5, 171-173.
2. Doganay L, Altaner S, Bilgi S, Kaya E, Ekuklu G, Kutlu K (2003) Expression of the cyclin-dependent kinase inhibitor p27 in transitional cell bladder cancers: is it a good predictor for tumor behavior? Int. Urol. Nephrol. 35, 181-188.
3. Evangelou K, Bramis J, Peros I, Zacharatos P, Dasiou-Plakida D, Kalogeropoulos N et al. (2004) Electron microscopy evidence that cytoplasmic localization of the p16(INK4A) "nuclear" cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact. A study in non-small cell lung carcinomas. Biotech. Histochem. 79, 5-10.
4. Gong Z, Fu J (2001) [Cyclin-dependent kinase 4 inhibitor a and tumor]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18, 219-221.
5. Iurisci I, Filipski E, Reinhardt J, Bach S, Gianella-Borradori A, Iacobelli S et al. (2006) Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor. Cancer Res. 66, 10720-10728.
6. Koutsodontis G, Tentes I, Papakosta P, Moustakas A, Kardassis D (2001) Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein. J. Biol. Chem. 276, 29116-29125.
7. Lagger G, Doetzlhofer A, Schuettengruber B, Haidweger E, Simboeck E, Tischler J et al. (2003) The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol. Cell. Biol. 23, 2669-2679.
8. Le XF, Claret FX, Lammayot A, Tian L, Deshpande D, LaPushin R et al. (2003) The role of cyclin-dependent kinase inhibitor p27Kip1 in anti-HER2 antibody-induced G1 cell cycle arrest and tumor growth inhibition. J. Biol. Chem. 278, 23441-23450.
9. Li G, Hundemer M, Wolfrum S, Ho AD, Goldschmidt H, Witzens-Harig M (2006) Identification and characterization of HLA-class-I-restricted T-cell epitopes in the putative tumor-associated antigens P21-activated serin kinase 2 (PAK2) and cyclin-dependent kinase inhibitor 1A (CDKN1A). Ann. Hematol. 85, 583-590.
10. Li J, Poi MJ, Qin D, Selby TL, Byeon IJ, Tsai MD (2000). Tumor suppressor INK4: quantitative structure-function analyses of p18INK4C as an inhibitor of cyclin-dependent kinase 4. Biochemistry 39, 649-657.
11. Li X, Tanaka K, Nakatani F, Matsunobu T, Sakimura R, Hanada M et al. (2005) Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells. Int. J. Cancer 116, 385-394.
12. Li Y, Tanaka K, Li X, Okada T, Nakamura T, Takasaki M et al. (2007) Cyclin-dependent kinase inhibitor, flavopiridol, induces apoptosis and inhibits tumor growth in drug-resistant osteosarcoma and Ewing's family tumor cells. Int. J. Cancer 121, 1212-1218.
13. Maziere C, Marcheux V, Louandre C, Maziere JC (2002) Oxidized low density lipoprotein induces the cyclin-dependent kinase inhibitor p21(waf1) and the tumor suppressor Rb. Biochem. Biophys. Res. Commun. 293, 1327-1332.
14. Wang Y, Joshi T, Zhang XS, Xu D, Chen L (2006) Inferring gene regulatory networks from multiple microarray datasets. Bioinformatics 22, 2413-2420.
15. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A et al. (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N. Engl. J. Med. 359, 1995-2004.
16. Storey JD (2002) A direct approach to false discovery rates. J. Roy. Stat. Soc., Ser. B 64, 479-498.
17. Leon LG, Donadel OJ, Tonn CE, Padron JM (2010) ip1 in anti-HER2 antibody-induced G1 cell cycle arrest and tumor growth inhibition. J. Biol. Chem. 278, 23441-23450.
18. Huang J, Wang L, Jiang M, Zheng X (2010) Interferon α-inducible protein 27 computational network construction and comparison between the frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. Open Genomics J. 3, 1-8.
19. Huang JX, Wang L, Jiang MH (2010) TNFRSF11B computational development network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. J. Inflamm. (Lond.) 7, 50.
20. Sun Y, Wang L, Jiang M, Huang J, Liu Z, Wolfl S (2009) Secreted phosphoprotein 1 upstream invasive network construction and analysis of lung adenocarcinoma compared with human normal adjacent tissues by integrative biocomputation. Cell Biochem. Biophys. 56, 59-71.
21. Sun Y, Wang L, Lui L (2008) Integrative decomposition procedure and Kappa statistics set up ATF2 ion binding module in malignant pleural mesothelioma (MPM). Front. Electrical Electronic Eng. China 3, 381-387.
22. Wang L, Huang J, Jiang M (2010) CREB5 Computational Regulation Network Construction and Analysis Between Frontal Cortex of HIV Encephalitis (HIVE) and HIVE-Control Patients. Cell Biochem. Biophys. 7, 50.
23. Wang L, Huang J, Jiang M (2010) RRM2 computational phosphoprotein network construction and analysis between no-tumor hepatitis/cirrhotic liver tissues and human hepatocellular carcinoma (HCC). Cell Physiol. Biochem. 26, 303-310.
24. Wang L, Huang J, Jiang M, Sun L (2010) MYBPC1 computational phosphoprotein network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. Cell. Mol. Neurobiol., 1573-6830 (Electronic), 0272-4340 (Linking).
25. Wang L, Huang J, Jiang M, Zheng X (2010) AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues. Tumour Biol. 31, 417-425.
26. Wang L, Sun Y, Jiang M, Zhang S, Wolfl S (2009) FOS proliferating network construction in early colorectal cancer (CRC) based on integrative significant function cluster and inferring analysis. Cancer Invest. 27, 816-824.
27. Wang L, Sun Y, Jiang M, Zheng X (2009) Integrative decomposition procedure and Kappa statistics for the distinguished single molecular network construction and analysis. J. Biomed. Biotechnol. 3, 381-387.
28. Leon LG, Donadel OJ, Tonn CE, Padron JM (2009) Tessaric acid derivatives induce G2/M cell cycle arrest in human solid tumor cell lines. Bioorg. Med. Chem. 17, 6251-6256.
29. Li D, Zhu J, Zhou Y, Liu X (2009) [Influence of DNAzymes against cyclin D1 in tumor cell cycle]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 26, 374-378.
30. Liang QC, Xiong H, Zhao ZW, Jia D, Li WX, Qin HZ et al. (2009) Inhibition of transcription factor STAT5b suppresses proliferation, induces G1 cell cycle arrest and reduces tumor cell invasion in human glioblastoma multiforme cells. Cancer Lett. 273, 164-171.
31. Lu X, Qian J, Yu Y, Yang H, Li J (2009) Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest. Oncol. Rep. 22, 635-640.
32. Ma S, Yang Y, Wang C, Hui N, Gu L, Zhong H et al. (2009) Endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest and apoptosis through down-regulation of the phosphatidylinositide 3-kinase/Akt/HDM2 pathway. J. Biol. Chem. 284, 24773-24782.
33. Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V et al. (2009) BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 30, 662-670.
34. Pecherzewska R, Nawrot B (2009) [FHIT - tumor suppressor protein involved in induction of apoptosis and cell cycle regulation]. Postepy Biochem. 55, 66-75.
35. Ritta M, De Andrea M, Mondini M, Mazibrada J, Giordano C, Pecorari G et al. (2009) Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. Head Neck 31, 318-327.
36. Scoumanne A, Zhang J, Chen X (2009) PRMT5 is required for cell-cycle progression and p53 tumor suppressor function. Nucleic Acids Res. 37, 4965-4976.
37. Skladanowski A, Bozko P, Sabisz M (2009) DNA structure and integrity checkpoints during the cell cycle and their role in drug targeting and sensitivity of tumor cells to anticancer treatment. Chem. Rev. 109, 2951-2973.
38. Stewart CJ, Crook ML, Leung YC, Platten M (2009) Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands. Mod. Pathol. 22, 725-733.
39. Teyssot ML, Jarrousse AS, Chevry A, De Haze A, Beaudoin C, Manin M et al. (2009) Toxicity of copper(I)-NHC complexes against human tumor cells: induction of cell cycle arrest, apoptosis, and DNA cleavage. Chemistry 15, 314-318.
40. Tu S, Wai-Yin Sun R, Lin MC, Tao Cui J, Zou B, Gu Q et al. (2009) Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer. Cancer 115, 4459-4469.
41. Varamini P, Soltani M, Ghaderi A (2009) Cell cycle analysis and cytotoxic potential of Ruta graveolens against human tumor cell lines. Neoplasma 56, 490-493.
42. Wrona IE, Lowe JT, Turbyville TJ, Johnson TR, Beignet J, Beutler JA et al. (2009) Synthesis of a 35-member stereoisomer library of bistramide A: evaluation of effects on actin state, cell cycle and tumor cell growth. J. Org. Chem. 74, 1897-1916.
43. Xie YF, Sheng W, Xiang J, Zhang H, Ye Z, Yang J (2009) Adenovirus-mediated ING4 expression suppresses pancreatic carcinoma cell growth via induction of cell-cycle alteration, apoptosis, and inhibition of tumor angiogenesis. Cancer Biother. Radiopharm. 24, 261-269.
44. Xiong H, Su WY, Liang QC, Zhang ZG, Chen HM, Du W et al. (2009) Inhibition of STAT5 induces G1 cell cycle arrest and reduces tumor cell invasion in human colorectal cancer cells. Lab. Invest. 89, 717-725.
45. Xu L, Niesen MI, Blanck G (2009) Linkage of a tumor immune function and cell cycle de-regulation via a gene regulatory network subcircuit. Mol. Immunol. 46, 569-575.
46. Zolochevska O, Figueiredo ML (2009) Expression of cell cycle regulator cdk2ap1 suppresses tumor cell phenotype by non-cell-autonomous mechanisms. Oral Oncol. 45, e106-e112.